Do oral steroids aid recovery in children with Bell's palsy?

Abdul Qader Ismail1, Oluwaseyi Alake2, Chetana Kallappa2

  • 1Paediatric Department, Good Hope Hospital, Sutton Coldfield, Birmingham, England aqt.ismail@bnc.oxon.org.

Insights

Steroids offer no significant benefit for pediatric Bell's palsy, as all children recovered regardless of treatment. Further research is needed for severe cases to avoid omitting potentially beneficial therapies.

Area of Science:

  • Pediatric Neurology
  • Otolaryngology

Background:

  • Bell's palsy affects children, causing facial nerve paralysis.
  • Steroid efficacy in pediatric Bell's palsy remains debated.
  • Evidence suggests limited benefit of steroids in this population.

Purpose of the Study:

  • To evaluate the effectiveness of steroid treatment in children with Bell's palsy.
  • To compare symptom duration in treated versus untreated pediatric Bell's palsy patients.

Main Methods:

  • Retrospective longitudinal study of 100 children over 12 years.
  • Analysis of medical records for facial nerve palsy diagnoses.
  • Comparison of symptom resolution intervals between steroid-treated and untreated Bell's palsy patients.

Main Results:

  • 79 children diagnosed with Bell's palsy; all achieved recovery.
  • No statistically significant difference in symptom duration between treated (median 5 weeks) and untreated (median 6 weeks) groups.
  • P-value of .86 indicates no significant difference.

Conclusions:

  • All children with Bell's palsy recovered irrespective of steroid treatment.
  • Current evidence does not support routine steroid use in pediatric Bell's palsy.
  • Further research is warranted for severe Bell's palsy cases to guide treatment decisions.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
703
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
695
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K